Clinical Trial: To Evaluate the Change in Blood Glucose Parameters in Adult Patients with Type 1 or Type 2 Diabetes from Europe Using the ICan O3 CGM System for a 60-day Period

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904846) titled 'To Evaluate the Change in Blood Glucose Parameters in Adult Patients with Type 1 or Type 2 Diabetes from Europe Using the ICan O3 CGM System for a 60-day Period' on March 17.

Brief Summary: This study is a post-market, prospective, interventional, multicenter clinical trial designed to evaluate the impact of the iCan O3 Continuous Glucose Monitoring (CGM) System on glycemic control in adults with Type 1 (T1D) or Type 2 Diabetes (T2D). Coordinated by Prof. Dr. Christophe De Block at Universitair Ziekenhuis Antwerpen (UZA), Belgium, and sponsored by Changsha Sinocare Inc., the study aims to assess changes in glucometric parameters ove...